Kinnate Biopharma Inc.
Related Filers (35)
- ORBIMED ADVISORS LLC (13)
- Williams Richard Thomas (11)
- GORDON CARL L (10)
- Krishnamohan Neha (10)
- Meltz Mark A (10)
- Foresite Capital Fund IV, L.P. (8)
- OrbiMed Capital GP VII LLC (7)
- Tananbaum James B. (7)
- Foresite Capital Fund V, L.P. (7)
- ORBIMED CAPITAL LLC (6)
- OrbiMed Genesis GP LLC (6)
- Foresite Capital Management V, LLC (5)
- Foresite Capital Management IV, LLC (5)
- Foresite Capital Opportunity Management V, LLC (5)
- Farzan Nima (5)
- Foresite Capital Opportunity Fund V, L.P. (5)
- OrbiMed Advisors IV Ltd (4)
- OrbiMed Asia GP IV, L.P. (4)
- OrbiMed Capital GP VIII LLC (4)
- Sabzevari Helen (4)
- MITCHELL DEAN J (4)
- Smaldone Alsup Laurie (4)
- Epperly Melissa B, (4)
- Flaherty Keith T. (4)
- RA CAPITAL MANAGEMENT, L.P. (4)
- Vida Ventures, LLC (3)
- Rome Michael E (3)
- Nextech V Oncology S.C.S., SICAV-SIF (3)
- Murphy Eric Anthony (2)
- FMR LLC (2)
- Lynx1 Capital Management LP (2)
- BlackRock Inc. (2)
- DeSimone Jill (2)
- TANG CAPITAL PARTNERS LP (2)
- Kaldor Stephen W (1)
- Show More ...
Financials (13)
10-Q
Thursday, 11/9/2023
Quarterly Report for period ending 2023-09-30
10-Q
Tuesday, 8/8/2023
Quarterly Report for period ending 2023-06-30
10-Q
Thursday, 5/11/2023
Quarterly Report for period ending 2023-03-31
10-K
Wednesday, 3/15/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/10/2022
Quarterly Report for period ending 2022-09-30
10-Q
Thursday, 8/11/2022
Quarterly Report for period ending 2022-06-30
10-K/A
Thursday, 5/12/2022
Annual Report for period ending 2021-12-31
10-Q
Thursday, 5/12/2022
Quarterly Report for period ending 2022-03-31
10-K
Monday, 3/28/2022
Annual Report for period ending 2021-12-31
10-Q
Wednesday, 11/10/2021
Quarterly Report for period ending 2021-09-30
10-Q
Monday, 8/16/2021
Quarterly Report for period ending 2021-06-30
10-Q
Monday, 5/17/2021
Quarterly Report for period ending 2021-03-31
10-K
Monday, 3/29/2021
Annual Report for period ending 2020-12-31
News (33)
8-K
Friday, 2/16/2024
Current report filing
8-K
Tuesday, 1/16/2024
Current report filing
8-K
Wednesday, 11/22/2023
Current report filing
8-K
Wednesday, 11/15/2023
Current report filing
8-K
Thursday, 11/9/2023
Current report filing
8-K
Monday, 9/18/2023
Current report filing
8-K
Tuesday, 8/8/2023
Current report filing
8-K
Friday, 7/28/2023
Current report filing
8-K
Monday, 6/12/2023
Current report filing
8-K
Thursday, 5/11/2023
Current report filing
8-K
Monday, 4/17/2023
Current report filing
8-K
Wednesday, 3/15/2023
Current report filing
8-K
Tuesday, 2/21/2023
Current report filing
8-K
Thursday, 1/26/2023
Current report filing
8-K
Thursday, 11/10/2022
Current report filing
8-K
Tuesday, 10/11/2022
Current report filing
8-K
Thursday, 8/11/2022
Current report filing
8-K
Wednesday, 6/15/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Monday, 3/28/2022
Current report filing
8-K
Tuesday, 1/18/2022
Current report filing
8-K
Thursday, 1/6/2022
Current report filing
8-K
Monday, 1/3/2022
Current report filing
8-K
Wednesday, 11/10/2021
Current report filing
8-K
Thursday, 10/28/2021
Current report filing
8-K
Monday, 8/16/2021
Current report filing
8-K
Monday, 6/28/2021
Current report filing
8-K
Tuesday, 6/15/2021
Current report filing
8-K
Monday, 6/7/2021
Current report filing
8-K
Monday, 5/17/2021
Current report filing
8-K
Thursday, 5/13/2021
Current report filing
8-K
Monday, 3/29/2021
Current report filing
8-K
Tuesday, 12/8/2020
Current report filing
Other (16)
ARS
Friday, 4/28/2023
Annual report to security holders
EFFECT
Tuesday, 4/26/2022
Notice of Effectiveness
POSASR
Monday, 3/28/2022
Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
POS AM
Monday, 3/28/2022
Post-effective amendment to a registration statement that is not immediately effective upon filing
EFFECT
Wednesday, 12/2/2020
Notice of Effectiveness
CORRESP
Wednesday, 12/2/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CERT
Tuesday, 12/1/2020
Certification by an exchange approving securities for listing
8-A12B
Monday, 11/30/2020
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Monday, 11/30/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 11/30/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 11/30/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 11/16/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 11/13/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D/A
Monday, 8/31/2020
Exempt (Private) Offering
D
Tuesday, 8/4/2020
Exempt (Private) Offering
D
Monday, 12/23/2019
Exempt (Private) Offering
Ownership (123)
SC 13G/A
Wednesday, 2/14/2024
TANG CAPITAL PARTNERS LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Lynx1 Capital Management LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Nextech V Oncology S.C.S., SICAV-SIF: Major Shareholders
4
Tuesday, 12/5/2023
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/5/2023
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/5/2023
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 11/27/2023
TANG CAPITAL PARTNERS LP: Major Shareholders
SC 13D/A
Friday, 11/17/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D/A
Friday, 11/17/2023
Foresite Capital Fund V, L.P.: Major Shareholders
SC 13D/A
Tuesday, 11/14/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D/A
Tuesday, 11/14/2023
Foresite Capital Fund V, L.P.: Major Shareholders
4
Wednesday, 9/6/2023
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/6/2023
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/6/2023
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 8/14/2023
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
4
Tuesday, 6/13/2023
Sabzevari Helen: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Epperly Melissa B,: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Flaherty Keith T.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
MITCHELL DEAN J: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Smaldone Alsup Laurie: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2023
Foresite Capital Fund IV, L.P.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2023
Tananbaum James B.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/10/2023
Foresite Capital Fund IV, L.P.: Major Shareholders
4
Monday, 5/8/2023
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Monday, 5/8/2023
GORDON CARL L: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 5/8/2023
ORBIMED ADVISORS LLC: Major Shareholders
SC 13D/A
Wednesday, 5/3/2023
ORBIMED ADVISORS LLC: Major Shareholders
4
Tuesday, 5/2/2023
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/2/2023
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 4/6/2023
BlackRock Inc.: Major Shareholders
4
Friday, 3/3/2023
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
3
Friday, 3/3/2023
DeSimone Jill: Initial statement of beneficial ownership of securities
4
Friday, 3/3/2023
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
DeSimone Jill: Statement of changes in beneficial ownership of securities
3
Thursday, 2/23/2023
OrbiMed Capital GP VIII LLC: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 2/23/2023
ORBIMED ADVISORS LLC: Major Shareholders
4
Thursday, 2/23/2023
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Foresite Capital Fund IV, L.P.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 2/22/2023
Foresite Capital Fund IV, L.P.: Major Shareholders
4
Wednesday, 2/22/2023
Tananbaum James B.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
GORDON CARL L: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 2/15/2023
Farzan Nima: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Nextech V Oncology S.C.S., SICAV-SIF: Major Shareholders
4
Tuesday, 2/14/2023
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2023
Farzan Nima: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2023
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
4
Tuesday, 2/14/2023
Meltz Mark A: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/13/2023
Vida Ventures, LLC: Major Shareholders
SC 13G
Friday, 2/3/2023
BlackRock Inc.: Major Shareholders
SC 13G
Monday, 1/23/2023
Lynx1 Capital Management LP: Major Shareholders
4
Friday, 12/2/2022
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Smaldone Alsup Laurie: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
MITCHELL DEAN J: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Tananbaum James B.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Rome Michael E: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Sabzevari Helen: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Flaherty Keith T.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Epperly Melissa B,: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/15/2022
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/15/2022
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/15/2022
Farzan Nima: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/15/2022
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/15/2022
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/15/2022
GORDON CARL L: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/15/2022
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G/A
Thursday, 2/10/2022
Vida Ventures, LLC: Major Shareholders
SC 13G/A
Wednesday, 2/9/2022
FMR LLC: Major Shareholders
4
Monday, 6/28/2021
Sabzevari Helen: Statement of changes in beneficial ownership of securities
3
Monday, 6/28/2021
Sabzevari Helen: Initial statement of beneficial ownership of securities
4
Monday, 6/14/2021
Smaldone Alsup Laurie: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Flaherty Keith T.: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
MITCHELL DEAN J: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Epperly Melissa B,: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/8/2021
Krishnamohan Neha: Initial statement of beneficial ownership of securities
4
Tuesday, 6/8/2021
Krishnamohan Neha: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/16/2021
Meltz Mark A: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/16/2021
Murphy Eric Anthony: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/16/2021
Williams Richard Thomas: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
4
Tuesday, 2/16/2021
Farzan Nima: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
Nextech V Oncology S.C.S., SICAV-SIF: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Vida Ventures, LLC: Major Shareholders
SC 13G
Monday, 2/8/2021
FMR LLC: Major Shareholders
SC 13D
Tuesday, 12/15/2020
Foresite Capital Fund IV, L.P.: Major Shareholders
SC 13D
Friday, 12/11/2020
ORBIMED ADVISORS LLC: Major Shareholders
4
Wednesday, 12/9/2020
Tananbaum James B.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/9/2020
Foresite Capital Management IV, LLC: Statement of changes in beneficial ownership of securities
Prospectus (14)
S-8
Friday, 3/17/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 3/28/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3ASR
Monday, 1/3/2022
Automatic shelf registration statement of securities of well-known seasoned issuers
424B4
Thursday, 12/3/2020
Prospectus filed pursuant to Rule 424(b)(4)
S-8
Thursday, 12/3/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-1/A
Wednesday, 12/2/2020
General form of registration statement for all companies including face-amount certificate companies
S-1MEF
Wednesday, 12/2/2020
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Monday, 11/30/2020
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 11/13/2020
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Tuesday, 11/3/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 11/3/2020
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 10/16/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 10/16/2020
Correspondence Related to Draft Registration Statement
DRS
Friday, 9/4/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (6)
DEF 14A
Friday, 4/28/2023
Definitive proxy statements
DEFA14A
Friday, 4/28/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Monday, 4/25/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 4/25/2022
Definitive proxy statements
DEF 14A
Friday, 4/30/2021
Definitive proxy statements
DEFA14A
Friday, 4/30/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.